Welcome to our dedicated page for Hca Healthcare news (Ticker: HCA), a resource for investors and traders seeking the latest updates and insights on Hca Healthcare stock.
HCA Healthcare operates a healthcare services network built around acute-care hospitals and ambulatory sites of care in the United States and the United Kingdom. Company news commonly addresses hospital operating trends, same-facility admissions, emergency room visits, inpatient and outpatient surgeries, revenue per equivalent admission and quarterly financial results.
Updates also cover capital allocation and financing activity, including dividends, share repurchase authorizations, commercial paper, senior notes issued by HCA Inc., and debt redemptions. Other recurring developments include hospital quality recognition, investor conference presentations, enterprise marketing and corporate affairs leadership, and the role of surgery centers, freestanding ERs, urgent care centers and physician clinics within HCA's ambulatory care platform.
HCA (NYSE: HCA) announced on April 27, 2026 that its subsidiary HCA Inc. proposes a public offering of senior notes, with final terms to be set at pricing. Net proceeds are planned for general corporate purposes, possibly repaying up to $4.000 billion of commercial paper and potentially redeeming up to $2.500 billion of near-term senior notes (5.250% due June 2026 and 5.375% due September 2026). Joint book-running managers are Citigroup, Barclays, BofA Securities and J.P. Morgan. The offering will be made via an effective shelf registration; details are in the preliminary prospectus supplement.
HCA Healthcare (NYSE: HCA) reported 1Q 2026 results: revenue $19.109B (+4.3%), net income $1.620B (+0.6%), and EPS $7.15 (+10.9%). Adjusted EBITDA was $3.802B (+1.9%).
Operating cash flow improved to $2.014B (+22.0%), share repurchases totaled $1.571B, dividend set at $0.78 per share, and 2026 guidance was reaffirmed.
HCA (NYSE:HCA) announced that 29 hospitals were named to Modern Healthcare’s 100 Top Hospitals Powered by Premier for 2026, with 7 hospitals receiving the Everest Award for sustained five‑year improvement.
Selection used objective CMS, MEDPAR and Medicare Cost Report data across 2,540 U.S. short‑term acute hospitals and highlights clinical, operational and patient experience performance.
HCA Healthcare (NYSE: HCA) will host its 1Q 2026 earnings conference call on Friday, April 24, 2026 at 9:00 AM Central (10:00 AM Eastern).
The event will be available as a live audio webcast and archived on the company investor website; investor and media contact names and phone numbers are provided for follow-up.
HCA Healthcare (NYSE:HCA) was named one of the 2026 World’s Most Ethical Companies by Ethisphere, marking its 16th recognition and placing it among four honorees in the Healthcare Providers and Services category. The award reflects documented ethics, compliance and governance practices evaluated by Ethisphere’s Ethics Quotient.
HCA highlighted 2025 community contributions: roughly $61.3M in giving, ~354,000 volunteer hours, $19.5M in colleague donations with matching, and $9.5M granted via the Hope Fund.
HCA Healthcare (NYSE:HCA) announced that 92 hospitals received the 2026 Healthgrades Patient Safety Excellence Award, recognizing the top 10% of U.S. hospitals for patient safety based exclusively on risk-adjusted outcomes.
The company highlighted decade-long operation of a federally listed Patient Safety Organization, 2024 implementation of the National Action Plan to Advance Patient Safety, and prior recognition of 44 HCA hospitals on Healthgrades America’s 250 Best Hospitals lists.
HCA Healthcare (NYSE: HCA) will present at multiple healthcare conferences in March 2026, with scheduled presentation dates and times listed by conference.
Live audio webcasts and presentation materials will be available in the Investor Relations section of the company website, www.hcahealthcare.com. Dates and times may change; check the conference schedule or the Investor Relations site for updates.
HCA Healthcare (NYSE:HCA) was named to Fortune’s 2026 World’s Most Admired Companies list and ranked No. 1 in its industry for the 12th consecutive year.
The company highlighted 2025 operational metrics: 54 research sites, > 6,600 patients enrolled across > 520 studies, > $40 million in tuition assistance to 11,700 colleagues, and > 9,200 Leadership Institute graduates in 2025.
HCA (NYSE:HCA) reported that 44 hospitals were named to Healthgrades America’s 250 Best Hospitals list for 2026, including 3 hospitals on America’s 50 Best Hospitals (top 1%) and 15 hospitals on America’s 100 Best Hospitals (top 2%).
Mission Hospital reached its 11th consecutive year on the America’s 50 Best list. Awards are based on risk-adjusted mortality and complication rates using CMS MedPAR data across multiple procedures and conditions.
HCA (NYSE: HCA) reported 4Q2025 revenues of $19.513B (up 6.7%) and net income of $1.878B (up 30.6%), with diluted EPS of $8.14 (up 44.6%). Adjusted EBITDA for 4Q2025 was $4.114B (up 10.8%). For the full year, 2025 revenues were $75.600B and net income was $6.784B. Balance sheet snapshots: cash and equivalents $1.040B, total debt $46.492B, total assets $60.720B. The company repurchased 5.432M shares for $2.558B in 4Q and the Board authorized an additional $10B repurchase program. The Board declared a quarterly dividend of $0.78 per share. 2026 guidance: revenues $76.5B–$80.0B, Adjusted EBITDA $15.55B–$16.45B, and EPS $29.10–$31.50.